Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Capital-Expenditures" stands at 1.57 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2018.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -59.79 percent compared to the value the year prior.
The 1 year change in percent is -59.79.
The 3 year change in percent is -25.45.
The 5 year change in percent is -5.07.
The 10 year change in percent is -43.25.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Capital Expenditures | 905,699,262,464.00 |
![]() | Johnson & Johnson - Capital Expenditures | 486,508,953,600.00 |
![]() | AbbVie Inc - Capital Expenditures | 399,570,305,024.00 |
![]() | Roche Holding AG - Capital Expenditures | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Capital Expenditures | 280,205,508,085.11 |